GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 372 filers reported holding GLOBUS MED INC in Q1 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,413,000 | +8.5% | 19,156 | +6.2% | 0.06% | +20.8% |
| Q4 2021 | $1,302,000 | -2.5% | 18,033 | +3.5% | 0.05% | -8.6% |
| Q3 2021 | $1,335,000 | -2.4% | 17,425 | -1.3% | 0.06% | +1.8% |
| Q2 2021 | $1,368,000 | +41.6% | 17,649 | +12.7% | 0.06% | +39.0% |
| Q1 2021 | $966,000 | -2.4% | 15,657 | +3.1% | 0.04% | -4.7% |
| Q4 2020 | $990,000 | +32.0% | 15,184 | +0.3% | 0.04% | +22.9% |
| Q3 2020 | $750,000 | +2.7% | 15,144 | -1.0% | 0.04% | 0.0% |
| Q2 2020 | $730,000 | +13.0% | 15,297 | +0.7% | 0.04% | -2.8% |
| Q1 2020 | $646,000 | -8.9% | 15,198 | +26.3% | 0.04% | +24.1% |
| Q4 2019 | $709,000 | +56.5% | 12,034 | +35.9% | 0.03% | +52.6% |
| Q3 2019 | $453,000 | +20.8% | 8,858 | -0.2% | 0.02% | +26.7% |
| Q2 2019 | $375,000 | -18.3% | 8,876 | -4.5% | 0.02% | -16.7% |
| Q1 2019 | $459,000 | +8.5% | 9,297 | -4.9% | 0.02% | -5.3% |
| Q4 2018 | $423,000 | -20.3% | 9,781 | +4.6% | 0.02% | 0.0% |
| Q3 2018 | $531,000 | +19.1% | 9,353 | +5.7% | 0.02% | +18.8% |
| Q2 2018 | $446,000 | -11.7% | 8,845 | -12.8% | 0.02% | -5.9% |
| Q1 2018 | $505,000 | +5.9% | 10,141 | -12.6% | 0.02% | +6.2% |
| Q4 2017 | $477,000 | +38.3% | 11,601 | +0.1% | 0.02% | +33.3% |
| Q3 2017 | $345,000 | -10.2% | 11,592 | +0.0% | 0.01% | -14.3% |
| Q2 2017 | $384,000 | +14.6% | 11,591 | +2.4% | 0.01% | +7.7% |
| Q1 2017 | $335,000 | +18.0% | 11,314 | -1.1% | 0.01% | +8.3% |
| Q4 2016 | $284,000 | +10.1% | 11,435 | +0.2% | 0.01% | +20.0% |
| Q3 2016 | $258,000 | -7.2% | 11,409 | -2.3% | 0.01% | -16.7% |
| Q2 2016 | $278,000 | +2.6% | 11,682 | +2.3% | 0.01% | +9.1% |
| Q1 2016 | $271,000 | -25.1% | 11,422 | -12.2% | 0.01% | -21.4% |
| Q4 2015 | $362,000 | +32.1% | 13,003 | -2.1% | 0.01% | +27.3% |
| Q3 2015 | $274,000 | -19.2% | 13,277 | +0.6% | 0.01% | -15.4% |
| Q2 2015 | $339,000 | +4.6% | 13,193 | +2.9% | 0.01% | +8.3% |
| Q1 2015 | $324,000 | +7.6% | 12,827 | +1.4% | 0.01% | 0.0% |
| Q4 2014 | $301,000 | +42.7% | 12,644 | +17.6% | 0.01% | +50.0% |
| Q3 2014 | $211,000 | -17.6% | 10,748 | +0.5% | 0.01% | -20.0% |
| Q2 2014 | $256,000 | – | 10,698 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |